Media Click chemistry targets antibody-drug conjugates for the clinic

July 5, 2019

Nature Biotechnology shares insights about click chemistry being tested in humans by the researchers at Memorial Sloan Kettering Cancer Center in New York. “Several biotech companies across the world are working on techniques that would shift bioorthogonal reactions from the lab into patients, potentially offering new ways unleash powerful cancer drugs and antibiotics in a controlled way.”

Read the full article by Mark Peplow on the website of Nature Biotechnology here.